UB Paderborn / Katalog / Suche / in CDI

1 – 6 von 6

Sortiert nach

Prediction of Transporter‐Mediated Drug‐Drug Interactions for Baricitinib

Clinical and translational science, 2017-11, Vol.10 (6), p.509-519

2017

Link zum Volltext

Verfügbarkeit prüfen

Effect of Ruboxistaurin on Albuminuria and Estimated GFR in People With Diabetic Peripheral Neuropathy: Results From a Randomized Trial

American journal of kidney diseases, 2015-04, Vol.65 (4), p.634-636

2015

Link zum Volltext

Verfügbarkeit prüfen

Oral protein kinase c β inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study 2

Retina (Philadelphia, Pa.), 2011-11, Vol.31 (10), p.2084

2011

Link zum Volltext

Verfügbarkeit prüfen

The effect of the oral PKC β inhibitor ruboxistaurin on vision loss in two phase 3 studies

Investigative ophthalmology & visual science, 2013-03, Vol.54 (3), p.1750-1757

2013

Link zum Volltext

Verfügbarkeit prüfen

Effect of ruboxistaurin (RBX) On visual acuity decline over a 6-year period with cessation and reinstitution of therapy: results of an open-label extension of the Protein Kinase C Diabetic Retinopathy Study 2 (PKC-DRS2)

Retina (Philadelphia, Pa.), 2011-06, Vol.31 (6), p.1053

2011

Link zum Volltext

Verfügbarkeit prüfen

P1-38　Evaluation of Potential Drug-Drug Interactions with Baricitinib

日本臨床免疫学会会誌, 2017, Vol.40(4), pp.307b-307b

井阪, 圭孝

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 6 von 6

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(5)
Mit Volltextzugriff
(4)

Publikationsform

Artikel
(6)

Sprache

Englisch
(5)
Japanisch
(2)

Erscheinungsjahr

n.n

Kollektion

MEDLINE
(5)
EZB Free E-Journals
(3)
IngentaConnect Journals
(2)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(2)
Ingenta
(2)
Single Journals
(2)
Wiley Online Library Journals
(1)
Elsevier ScienceDirect Journals Complete
(1)

3 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prediction of Transporter‐Mediated Drug‐Drug Interactions for Baricitinib

Effect of Ruboxistaurin on Albuminuria and Estimated GFR in People With Diabetic Peripheral Neuropathy: Results From a Randomized Trial

Oral protein kinase c β inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study 2

The effect of the oral PKC β inhibitor ruboxistaurin on vision loss in two phase 3 studies

Effect of ruboxistaurin (RBX) On visual acuity decline over a 6-year period with cessation and reinstitution of therapy: results of an open-label extension of the Protein Kinase C Diabetic Retinopathy Study 2 (PKC-DRS2)

P1-38　Evaluation of Potential Drug-Drug Interactions with Baricitinib

Suchergebnisse filtern

Prediction of Transporter‐Mediated Drug‐Drug Interactions for Baricitinib

Effect of Ruboxistaurin on Albuminuria and Estimated GFR in People With Diabetic Peripheral Neuropathy: Results From a Randomized Trial

Oral protein kinase c β inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study 2

The effect of the oral PKC β inhibitor ruboxistaurin on vision loss in two phase 3 studies

Effect of ruboxistaurin (RBX) On visual acuity decline over a 6-year period with cessation and reinstitution of therapy: results of an open-label extension of the Protein Kinase C Diabetic Retinopathy Study 2 (PKC-DRS2)

P1-38 Evaluation of Potential Drug-Drug Interactions with Baricitinib

Suchergebnisse filtern

P1-38　Evaluation of Potential Drug-Drug Interactions with Baricitinib